{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:58:02Z","timestamp":1788404282976,"version":"build-2803163510"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Central nervous system infection (CNSI) treatment in hospital neurosurgery emphasizes the importance of optimizing antimicrobial therapy. Timely and appropriate empiric antibiotic treatment is critical for managing patients with bacterial meningitis.<\/jats:p><jats:p><jats:bold>Objectives:<\/jats:bold> To evaluate the activities of clinical pharmacists in the anti-infective treatment of patients with CNSI in neurosurgery.<\/jats:p><jats:p><jats:bold>Method:<\/jats:bold> A single-center retrospective cohort study was carried out from January 2021 to March 2023 at a tertiary teaching hospital in China. The study sample included a group that received pharmacy services and a group that did not. In the pharmacy services group, the anti-infective treatment plan was led and developed by pharmacists. Pharmaceutical care, including medication therapy and all CNSI treatment regimens, was administered in daily unit rounds by pharmacists. Baseline demographics, treatment outcomes, and rational use of antibiotics were compared between the two groups, and the impact of a antimicrobial stewardship (AMS) program was evaluated.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Of the 306 patients assessed according to the inclusion and exclusion criteria, 151 patients were included, and 155 patients were excluded due to abnormal data and missing information on antibiotic costs or antimicrobial use. Eventually, 73 were included in the pharmacy services group and 78 in the group without pharmacist participation. The antibiotic use density (AUD) of the pharmacy services group decreased from 167.68 to 127.63 compared to the group without pharmacist participation. After the pharmacist services, the AUD for linezolid decreased from 9.15% to 5.23% and that for miscellaneous agents decreased from 17.91% to 6.72%. The pharmacy services group had better improvement (<jats:italic>p &amp;lt; 0.05<\/jats:italic>) and a significantly higher score for the rational use of antibiotics (<jats:italic>p &amp;lt; 0.05<\/jats:italic>) than the group without pharmacist participation.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The clinical pharmacist services evaluation results demonstrated an essential role of clinical pharmacist-led AMS programs in the effective and appropriate use of anti-infective treatments in neurosurgery with patients with CNSI.<\/jats:p>","DOI":"10.3389\/fphar.2023.1226333","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T07:55:05Z","timestamp":1694073305000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The participation of clinical pharmacists in the treatment of patients with central nervous system infection can improve the effectiveness and appropriateness of anti-infective treatments: a retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Jie","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChuanDong","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianJun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XueYan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e018255","DOI":"10.1128\/AAC.01825-17","article-title":"A before-and-after study of the effectiveness of an antimicrobial stewardship program in critical care","volume":"62","author":"\u00c1lvarez-Lerma","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/978-1-4471-5226-2_22","article-title":"Central nervous system infections","author":"Archibald","year":"2013","journal-title":"Textb. Neurointensive Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.japh.2021.10.005","article-title":"Cost-effectiveness analysis of pharmacist interventions in patients with heart failure in Thailand","volume":"62","author":"Arunmanakul","year":"2022","journal-title":"J. Am. Pharm. Assoc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/cid\/ciw217","article-title":"Executive summary: Implementing an antibiotic stewardship program: Guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s11096-011-9538-6","article-title":"Clinical pharmacist interventions on a UK neurosurgical critical care unit: A 2-week service evaluation","volume":"33","author":"Bourne","year":"2011","journal-title":"Int. J. Clin. Pharm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.11606\/s1518-8787.2020054001895","article-title":"Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital","volume":"54","author":"Cazarim","year":"2020","journal-title":"Rev. sa\u00fade p\u00fablica"},{"key":"B7","unstructured":"Core elements of hospital antibiotic stewardship programs2019"},{"key":"B8","volume-title":"Clinical pharmacist training guide","year":"2008"},{"key":"B9","volume-title":"Statistical bulletin of the people\u2019s Republic of China on national economic and social development 2022","author":"China National Bureau of Statistics","year":"2023"},{"key":"B10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.emc.2016.06.013","article-title":"Diagnosis and treatment of central nervous system infections in the emergency department","volume":"34","author":"Dorsett","year":"2016","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1007\/s11096-018-0691-z","article-title":"Pharmacist\u2019s interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: A randomized trial","volume":"40","author":"Falami\u0107","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s11096-014-0008-9","article-title":"Economic evaluations of clinical pharmacist interventions on hospital inpatients: A systematic review of recent literature","volume":"36","author":"Gallagher","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0208447","DOI":"10.1371\/journal.pone.0208447","article-title":"Opportunities and barriers to implementing antibiotic stewardship in low and middle-income countries: Lessons from a mixed-methods study in a tertiary care hospital in Ethiopia","volume":"13","author":"Gebretekle","year":"2018","journal-title":"PLoS ONE"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/INF.0b013e31817e519b","article-title":"Traumatic lumbar punctures in neonates: Test performance of the cerebrospinal fluid white blood cell count","volume":"27","author":"Greenberg","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e36067","DOI":"10.7759\/cureus.36067","article-title":"Results of a pilot study for a pharmacy discharge review in neurosurgical patients: A quality-safety initiative","volume":"15","author":"Greenwood","year":"2023","journal-title":"Cureus"},{"key":"B19","volume-title":"Benefits of pharmacist intervention in the critical care patients with infectious diseases: A propensity score matching retrospective cohort study","author":"Gu","year":"2023"},{"key":"B20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3171\/2016.10.JNS16379","article-title":"Development of a prediction rule for diagnosing postoperative meningitis: A cross-sectional study","volume":"128","author":"Hern\u00e1ndez Ortiz","year":"2018","journal-title":"J. Neurosurg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care\u2013associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am. J. Infect. Control"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.cmi.2016.01.001","article-title":"Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005\u20132014","volume":"22","author":"Hu","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1007\/s11096-018-0733-6","article-title":"Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital","volume":"40","author":"Jourdan","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"B25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/0272989X211019040","article-title":"The application of multicriteria decision analysis methods in health care: A literature review","volume":"42","author":"Khan","year":"2022","journal-title":"Med. Decis. Mak."},{"key":"B26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/healthcare10030512","article-title":"Priorities in the prevention strategies for medication error using the analytical hierarchy process method","volume":"10","author":"Kim","year":"2022","journal-title":"Healthcare"},{"key":"B27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/antibiotics11020219","article-title":"Pharmacists\u2019 perspectives of their roles in antimicrobial stewardship: A qualitative study among hospital pharmacists in Malaysia","volume":"11","author":"Lai","year":"2022","journal-title":"Antibiotics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e9308","DOI":"10.1097\/MD.0000000000009308","article-title":"Development of indicators for assessing rational drug use to treat community-acquired pneumonia in children in hospitals and clinics: A modified delphi study","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"106266","DOI":"10.1016\/j.ejps.2022.106266","article-title":"Norvancomycin for the treatment of central nervous system mrsa infections: A randomized controlled trial","volume":"177","author":"Li","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/sur.2015.060","article-title":"Empirical combination antibiotic therapy improves the outcome of nosocomial meningitis or ventriculitis in neuro-critical care unit patients","volume":"17","author":"Li","year":"2016","journal-title":"Surg. Infect."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1017\/ice.2015.136","article-title":"Factors influencing antibiotic-prescribing decisions among inpatient physicians: A qualitative investigation","volume":"36","author":"Livorsi","year":"2015","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40199-016-0148-7","article-title":"A model for priority setting of health technology assessment: The experience of AHP-TOPSIS combination approach","volume":"24","author":"Mobinizadeh","year":"2016","journal-title":"DARU J. Pharm. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/bcpt.12802","article-title":"Clinical effects of a pharmacist intervention in acute wards \u2013 a randomized controlled trial","volume":"121","author":"Nielsen","year":"2017","journal-title":"Basic and Clin. Pharmacol. Toxicol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13756-018-0305-5","article-title":"Efficacy of intravenous plus intrathecal\/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR\/XDR acinectobacter baumannii: A retrospective cohort study","volume":"7","author":"Pan","year":"2018","journal-title":"Antimicrob. Resist Infect. Control"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1111\/bcp.15279","article-title":"Effects of pharmacist interventions on cardiovascular risk factors and outcomes: An umbrella review of meta-analysis of randomized controlled trials","volume":"88","author":"Rattanavipanon","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0377-2217(90)90057-i","article-title":"How to make a decision: The analytic hierarchy process","volume":"48","author":"Saaty","year":"1990","journal-title":"Eur. J. Operational Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/phar.1923","article-title":"ACCP clinical pharmacist competencies","volume":"37","author":"Saseen","year":"2017","journal-title":"Pharmacotherapy"},{"key":"B38","first-page":"861","article-title":"Research progress in the treatment of intracranial infections with antibiotics","volume":"45","author":"Shun-xiao","year":"2020","journal-title":"Chin. J. ANTIBIOTICS"},{"key":"B39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1331\/JAPhA.2012.12501","article-title":"DOTx.MED: Pharmacist-delivered interventions to improve care for patients with diabetes","volume":"52","author":"Skelton","year":"2012","journal-title":"J. Am. Pharm. Assoc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/MCC.0000000000000397","article-title":"Central nervous system infections in immunocompromised patients","volume":"23","author":"Sonneville","year":"2017","journal-title":"Curr. Opin. Crit. Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1517\/14656566.2015.973851","article-title":"Treatment strategies for central nervous system infections: An update","volume":"16","author":"Tan","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e968","DOI":"10.1016\/S2214-109X(19)30201-3","article-title":"Cost-effectiveness and cost-utility of population-based glaucoma screening in China: A decision-analytic markov model","volume":"7","author":"Tang","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"B43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/589747","article-title":"The management of encephalitis: Clinical practice guidelines by the infectious diseases society of America","volume":"47","author":"Tunkel","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 infectious diseases society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3760\/cma.j.cn112050-20200831-00480","article-title":"Chinese expert consensus on the diagnosis and treatment of central nervous system infections in neurosurgery","volume":"37","author":"Wang","year":"2021","journal-title":"Chin. J. Neurosurg."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1012690","DOI":"10.3389\/fpubh.2022.1012690","article-title":"The impact of pharmacist-led antimicrobial stewardship program on antibiotic use in a county-level tertiary general hospital in China: A retrospective study using difference-in-differences design","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Public Health"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1177\/1060028019864669","article-title":"The role of the clinical pharmacist in a preventive cardiology practice","volume":"53","author":"Warden","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1227\/01.NEU.0000347090.22818.35","article-title":"Cost effectiveness of A clinical pharmacist on A neurosurgical team","volume":"65","author":"Weant","year":"2009","journal-title":"Neurosurgery"},{"key":"B50","volume-title":"WHO collaborating centre for drug statistics methodology, guidelines for ATC classification and DDD assignment 2023 (oslo, Norway)","year":"2022"},{"key":"B51","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/ijpp.12595","article-title":"Competence and confidence with prescribing in pharmacy and medicine: A scoping review","volume":"28","author":"Woit","year":"2020","journal-title":"Int. J. Pharm. Pract."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.832078","article-title":"The impact of a multifaceted pharmacist-led antimicrobial stewardship program on antibiotic use: Evidence from a quasi-experimental study in the department of vascular and interventional radiology in a Chinese tertiary hospital","volume":"13","author":"Xu","year":"","journal-title":"Front. Pharmacol."},{"key":"B53","article-title":"Pharmacist-led intervention in managing unreasonable use of apatinib based on AHP-TOPSIS analysis","author":"Xu","year":"","journal-title":"Lat. Am. J. Pharm"},{"key":"B54","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ncl.2019.01.002","article-title":"Central nervous system vasculitis due to infection","volume":"37","author":"Younger","year":"2019","journal-title":"Neurol. Clin."},{"key":"B55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/ejhpharm-2018-001815","article-title":"Evaluation of a clinical pharmacist consultation service for patients with infectious diseases in China: A systematic review and meta-analysis","volume":"27","author":"Zhang","year":"","journal-title":"Eur. J. Hosp. Pharm."},{"key":"B56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fphar.2020.00149","article-title":"The clinical pharmacist-led consultation for infectious diseases in guizhou Province, China: A survey among hospital pharmacies","volume":"11","author":"Zhang","year":"","journal-title":"Front. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12879-021-06561-2","article-title":"Epidemiology of patients with central nervous system infections, mainly neurosurgical patients: A retrospective study from 2012 to 2019 in a teaching hospital in China","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Infect. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1226333\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T07:55:15Z","timestamp":1694073315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1226333\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":54,"alternative-id":["10.3389\/fphar.2023.1226333"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1226333","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"article-number":"1226333"}}